Literature DB >> 6120794

How informed is informed consent? The BHAT experience.

J M Howard, D DeMets.   

Abstract

In the Beta-blocker Heart Attack Trial (BHAT) a number of strategies were implemented to increase the probability of informed voluntary consent among survivors of an acute myocardial infarction. To evaluate the subjects' comprehension of the study, a bioethicist conducted in-depth home interviews with a random sample of 64 participants from 11 geographic areas. The great majority of respondents proved to be well informed about the study design, its scientific logic, and possible risks of the experimental drug. However, five subjects (8% of the sample) appeared to believe they were involved in a therapeutic program rather than a research project. The analysis of predictor variables indicates that education, race, and age were associated with the degree of respondent awareness of fundamental aspects of the trial.

Entities:  

Keywords:  Beta-Blocker Heart Attack Trial (BHAT); Biomedical and Behavioral Research; Empirical Approach

Mesh:

Substances:

Year:  1981        PMID: 6120794     DOI: 10.1016/0197-2456(81)90019-2

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  30 in total

Review 1.  Improving the informed consent process for research subjects with low literacy: a systematic review.

Authors:  Leonardo Tamariz; Ana Palacio; Mauricio Robert; Erin N Marcus
Journal:  J Gen Intern Med       Date:  2012-07-11       Impact factor: 5.128

Review 2.  The quality of informed consent: mapping the landscape. A review of empirical data from developing and developed countries.

Authors:  Amulya Mandava; Christine Pace; Benjamin Campbell; Ezekiel Emanuel; Christine Grady
Journal:  J Med Ethics       Date:  2012-02-07       Impact factor: 2.903

Review 3.  Clinical research with economically disadvantaged populations.

Authors:  Colleen C Denny; Christine Grady
Journal:  J Med Ethics       Date:  2007-07       Impact factor: 2.903

4.  Consent in medical decision making: the role of communication.

Authors:  W C Wu; R A Pearlman
Journal:  J Gen Intern Med       Date:  1988 Jan-Feb       Impact factor: 5.128

5.  The use of multimedia in the informed consent process.

Authors:  H B Jimison; P P Sher; R Appleyard; Y LeVernois
Journal:  J Am Med Inform Assoc       Date:  1998 May-Jun       Impact factor: 4.497

6.  Patient awareness and approval for an opt-out genomic biorepository.

Authors:  Kyle B Brothers; Mathew J Westbrook; M Frances Wright; John A Myers; Daniel R Morrison; Jennifer L Madison; Jill M Pulley; Ellen Wright Clayton
Journal:  Per Med       Date:  2013-06       Impact factor: 2.512

7.  A randomized controlled trial of an electronic informed consent process.

Authors:  Erin Rothwell; Bob Wong; Nancy C Rose; Rebecca Anderson; Beth Fedor; Louisa A Stark; Jeffrey R Botkin
Journal:  J Empir Res Hum Res Ethics       Date:  2014-10-02       Impact factor: 1.742

8.  Primary care physicians' attitudes and beliefs about cancer clinical trials.

Authors:  Carma L Bylund; Elisa S Weiss; Margo Michaels; Shilpa Patel; Thomas A D'Agostino; Emily B Peterson; Maria Christina Binz-Scharf; Natasha Blakeney; M Diane McKee
Journal:  Clin Trials       Date:  2017-07-11       Impact factor: 2.486

9.  Informed consent, parental awareness, and reasons for participating in a randomised controlled study.

Authors:  M van Stuijvenberg; M H Suur; S de Vos; G C Tjiang; E W Steyerberg; G Derksen-Lubsen; H A Moll
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

Review 10.  The doctor's duty to the elderly patient in clinical trials.

Authors:  Antony Bayer; Mark Fish
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.